Corrigendum: Biochemical Pathways Triggered by Antipsychotics in Human Oligodendrocytes: Potential of Discovering New Treatment Targets
- 1Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas, Brazil
- 2Faculdade de Palmas, Palmas, Brazil
- 3UNICAMP's Neurobiology Center, Campinas, Brazil
- 4Instituto Nacional de Biomarcadores em Neuropsiquiatria, Conselho Nacional de Desenvolvimento Científico e Tecnológico, São Paulo, Brazil
by Brandão-Teles, C., de Almeida, V., Cassoli, J. S., and Martins-de-Souza, D. (2019). Front. Pharmacol. 10:186. doi: 10.3389/fphar.2019.00186
The title of the article has been changed from “Oligodendrocytes: Potential of Discovering New Treatment Targets” to “Biochemical Pathways Triggered by Antipsychotics in Human Oligodendrocytes: Potential of Discovering New Treatment Targets.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: schizophrenia, mechanism of action, proteomics, biomarkers, chlorpromazine, haloperidol, quetiapine, risperidone
Citation: Brandão-Teles C, de Almeida V, Cassoli JS and Martins-de-Souza D (2019) Corrigendum: Biochemical Pathways Triggered by Antipsychotics in Human Oligodendrocytes: Potential of Discovering New Treatment Targets. Front. Pharmacol. 10:344. doi: 10.3389/fphar.2019.00344
Received: 18 March 2019; Accepted: 19 March 2019;
Published: 09 April 2019.
Approved by:Frontiers in Pharmacology Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2019 Brandão-Teles, de Almeida, Cassoli and Martins-de-Souza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.